ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase ...

The advent of these new advanced systemic drugs since 2017, including biologics (i.e. dupilumab and tralokinumab) and Janus kinase (JAK)-inhibitors (i.e. baricitinib, upadacitinib and abrocitinib), ...

Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against ...

Dupixent became the first biologic therapy approved by the FDA for the condition in 2017, while Cibinqo, part of a class of ...

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine are closer to understanding what drives the ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

Anaemia in myelofibrosis is a multifaceted challenge with a significant impact on patient outcomes, writes Theresa Lowry ...

Demonstrating improvements in patient quality of life using patient-reported outcomes are important for treatments for myeloproliferative neoplasms (MPNs), said Jennifer Vaughn, MD, of The Ohio State ...

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...